New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring. A new type of molecular imaging may help quickly identify the first signs of pulmonary ...

United Therapeutics’ UTHR fourth-quarter 2024 earnings of $6.19 per share beat the Zacks Consensus Estimate of $6.10. Earnings rose 42% year over year on the back of higher product sales.

Its Keytruda drug for cancer treatment is performing well, and the launch of Winrevair, a drug that treats pulmonary arterial hypertension (PAH), is also boosting revenue growth for the company.

Males with pulmonary arterial hypertension (PAH) have more proinflammatory macrophages — a type of immune cell — in the lungs than do females with the disease, a study suggests. Researchers identified ...

In fact, a recent study suggests that board-certified physicians specializing in heart and lung conditions may correctly suspect PH less than 50% of the time. Because PAH can be severe and often ...

A team at Memorial Sloan Kettering has been working to improve those outcomes by developing a new mRNA vaccine for pancreatic cancer. A few years ago, the team embarked on a small trial to test the ...

我们查到耶鲁官网信息，该研究发布于预印本网站，内容未涉及任何具体患者信息。课题组选取了42名受PVS困扰的患者，他们半数接种了Moderna的mRNA疫苗，其次是辉瑞或强生疫苗，将他们和22名未产生疫苗副反应的人进行对比。结果显示，PVS组免疫T细胞水平与对照 ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo ...

Vaccines using messenger RNA, or mRNA, technology became widespread during the pandemic. With limited long-term studies available, the Trump administration is revisiting these vaccines. In response to ...